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Abstract 
The nucleophilic addition of 4-aminophenol 1 to 2-chloro-N, N-dimethyethylamine 2 generated 
intermediate 3. Following oxidation facilitated by [bis(trifluoroacetoxy)iodo]benzene (PIFA, 4) 
created quinoneimine 5. Then, Compound 5 went under nucleophilic Michael Addition with 3-
mercaptopropionic acid and subsequent cyclization with coupling reagent N,N'-
dicyclohexylcarbodiimide (DCC) 7, to generate the desired analogs of Diltiazem/Clentiazem 8. 
This four-step total synthesis approach provides a high yielding novel synthesis methodology. 
   
Scheme 1. General Synthesis of Analogs of Diltiazem/Clentiazem 
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Introduction 
 In today’s society, cardiovascular diseases are rampant. According to the World Health 
Organization, cardiovascular disease accounts for 30% of all global deaths
1
. Therefore, 
researchers put a big effort into trying to find a drug that will cure these diseases. Drugs 
containing a benzothiazepinone core structure are known to be potent in treating cardiovascular 
diseases.
2
 Thus, researchers have synthesized benzothiazepinones such as Diltiazem and 
Clentiazem and their analogs, Figure 1. A Chinese team synthesized benzothiazepinone 
derivatives from 1,5-difluoro-2,4-dinitrobenzene.
3 
Whereas, a Japanese team synthesized 
benzothiazepinone derivatives through fusion of the halogen-substituted 2-aminothiophenol with 
the trans-3arylglycidic ester.
4
 Just like these scientists, the purpose of this research is to propose 
a new synthetic route to benzothiazepinones that will have shorter reaction steps with cheaper 
starting materials. To test the potency of the drug, the final product will be tested as a potential 
vasodilator or calcium antagonist at a later determined time. By creating a shorter and more 
affordable route to benzothiazepinone, we hope to impact society with a more effective 
cardiovascular drug. 
  
 
 
 
Figure 1.  Diltiazem and Clentiazem structures 
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Methods 
 
 
The total synthesis of Diltiazem/Clentiazem analogs had two different pathways: Route 1 
and Route 2 which are demonstrated in Figure 2. Bold numbers from the following passage and 
figures refer to their corresponding compounds as it is listed in Figure 2. In Route 1, 
nucleophilic addition of aniline 9, to 2-chloro-N,N-dimethyethylamine 2, successfully generated 
dimethyl[2-(phenylamino)ethyl]amine 10. However, oxidation of compound 10 was 
unsuccessful which led to the design of an alternative pathway. Therefore, in Route 2, 
nucleophilic addition of 4-aminophenol 1, to 2-chloro-N, N-dimethyethylamine 2, generated 
intermediate 3. This intermediate was oxidized by PIFA, followed by nucleophilic Michael 
addition of 3-mercaptopropionic acid 6. Lastly, cyclization with DCC 7 generated the 
Diltiazem/Clentiazem analogs 8. 
Nucleophilic addition of 4-aminophenol to 2-chloro-N, N-dimethyethylamine
5 
In the nucleophilic addition, 12 mL of acetonitrile (ACN) was added to 0.5 mmol of 
potassium iodide (KI). Then, 5 mmol of potassium carbonate (K2CO3), and 15 mmol of 4-
Figure 2. Overall synthetic pathways of Diltiazem/Clentiazem analogs 
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aminophenol 1 were added respectively to the solution. Lastly, 5 mmol of 2-chloro-N, N-
dimethyethylamine 2 were added to the mixture, and the reaction was left heating for 7 days at 
110C. Then, the mixture was purified through flash column chromatography using ethyl acetate: 
methanol: and ammonia (85:15:0.1) as a solvent system. The resulting product was dried in 
vacuo and (4-{[2-(dimethylamino)ethyl]amino}phenol), compound 3, was formed. 
Oxidation of (4-{[2-(dimethylamino)ethyl]amino}phenol)
6 
 In the oxidation step, 0.227 mmol of the compound 3 was dissolved into 
acetonitrile:water (2:1, 0.680mL). Then, 0.227 mmol of PIFA 4 was added to the solution. The 
reaction vial was covered in aluminum foil and left stirring in room temperature for a week. This 
reaction produced in situ 4-{[2-(dimethylamino)ethyl]imino}cyclohexa-2,5-dien-1-one 5. The 
reaction mixture was used onto the next step without further purification and monitored by thin 
layer chromatography (TLC).  Once TLC detected a new spot and the starting material was 
consumed, the solvent was dried in vacuo and stored to be used onto the following step.
 
Michael addition of 3-mercaptopropionic acid
7
  
 To a solution of 0.227 mmol of oxidized compound dissolved in 1.89 mL of ethanol 
(EtOH), a solution of 0.227 mmol of 3-mercaptopropionic acid was added and the mixture was 
stirred at room temperature for two days. Like the previous reaction, the addition of 3-
mercaptopropionic acid was monitored through TLC. This reaction produced 3-[(2-{[2-
(dimethylamino)ethyl]amino}-5-hydroxyphenyl)sulfanyl]propanoic acid, compound 6a, which 
was evaporated in vacuo as well. 
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Cyclization of 3-[(2-{[2-(dimethylamino)ethyl]amino}-5-hydroxyphenyl)sulfanyl]propanoic 
acid
7 
 A solution of 0.227 mmol of compound 6a was dissolved into 1 mL of tetrahydrofuran 
(THF). Then, 0.227 mmol of DCC 7 was added to the solution. The solution was left stirring at 
room temperature for four days. On the fourth day, TLC detected the presence of a new spot, so 
flash column chromatography was performed. The eluent solvent system was ethyl acetate: 
methanol: and ammonia (85:15:0.1). The compound was isolated and the solvent was evaporated 
in vacuo. This reaction should have produced 5-[2-(dimethylamino)ethyl]-8-hydroxy-2,3,4,5-
tetrahydro-1,5-benzothiazepin-4-one 8, which is a Diltiazem/Clentiazem analog.  Data analysis 
of this step is in progress. 
Results and Discussion 
Nucleophilic addition of 4-aminophenol to of 2-chloro-N, N-dimethyethylamine 
 This reaction was run in two different ways: a front-run and a large scale. The front-run 
produced 0.316g, 1.75 mmol, 35% yield. Whereas, the large scale yielded 3.500g, 18.6 mmol, 
93% yield. The yield in the large scale run improved greatly due to having more material to work 
with and an increase in technical knowledge and laboratory ability. The same purification 
procedure was conducted for the column chromatography of both runs. Furthermore, both runs 
isolated desired products and were analyzed by Dr. Herman H. Odens, the lead researcher, with 
the courtesy of University of Tennessee at Chattanooga.  Samples were analyzed by 
1
H and 
13
C 
NMR using a Jeol 400MHz NMR.  The 
1
H NMR spectrum of the front-run is illustrated in 
Figure 3. Likewise, the large scale reaction 
1
H NMR spectrum is illustrated in Figure 4.  
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1
H NMR of the front-run and of the large scale are just as anticipated. All the expected 
peaks are present and very few impurities are shown. Thus, the nucleophilic addition reaction 
was conducted successfully. However, from the oxidation step  onward, the researchers carried 
out the total synthesis with no purification. Therefore, the results for the final  synthesis of 
Diltiazem and Clentiazem analogs are still in progress. 
 
Figure 3. 
1
H NMR of the front-run of compound 3 
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In the nucleophilic step, there was a possibility of O-alkylation instead of N-alkylation. 
However, both TLC and 
1
H
 
NMR revealed that no such alkylation occurred. In fact, NMR 
showed no trace of O-alkylation. This trend is consistent with common nucleophilicity 
knowledge. Nitrogen is less electronegative and a better base than the oxygen atom, which 
makes N-alkylation much more likely to happen.  
 This successful SN2 reaction is masked by the failure of Route 1, Figure 2, synthesis. As 
in Route 2 nucleophilic reaction, the Route 1 nucleophilic reaction was fundamentally 
successful and produced N
1
-ethyl-N
2
,N
2
-dimethyl-N
1
-phenyl-1,2-ethanediamine, 11 . However, 
the insertion of a hydroxyl group to this molecule was unsuccessful. The TLC revealed a 
Figure 4. H
1
 NMR of DSJC7-23 from large scale 
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breakdown of product and 
1
H NMR showed too many peaks to have any meaningful 
interpretation. Thus, realizing the difficulty of inserting a hydroxyl group to N
1
-ethyl-N
2
,N
2
-
dimethyl-N
1
-phenyl-1,2-ethanediamine 11, the same reaction conditions were used in Route 2 
with 4-aminophenol instead of aniline. This strategy not only gave a better result but also cut 
down on total synthetic steps. 
 In the second step of Route 2, the oxidation of (4-{[2(dimethylamino)ethyl]amino}phenol) 
compound 3 had several problems.  The compound is heat and light sensitive, and also breaks 
down in silica gel. Thus, no purification was done from this oxidation step onward because flash 
column chromatography requires silica gel. Because of these sensitivities, four different 
oxidizing agents were tried to find the best one, Figure 5. According to TLC, treatment of 
compound 3 with PIFA 4 was the only reaction that successfully oxidized the (4-{[2-
(dimethylamino)ethyl]amino}phenol) 3.  However, an attempt to isolate compound 5 by column 
chromatography was unsuccessful.  
  
 Figure 5. Explosion chart of various oxidizing agents 
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The oxidation steps show that redox reactions are usually substrate specific and not all 
oxidants can oxidize the same molecule. Compound 3 seems to favor PIFA 4 over the others. 
When Ag2O, KMnO4, and NaIO4 were used as oxidants, TLC showed many spots which are an 
indication of multiple product formation. Possible causes for this would be over oxidation and 
degradation of compounds, which was evident from TLC data of these three reactions. However, 
exact reason why compound 3 favors PIFA is unclear. 
Conclusion:  
Although the research was slow in the beginning, a new methodology, Route 2, has been 
successfully developed for the synthesis of Diltiazem/Clentiazem analogs. In the future, addition 
of chiral groups to the 7-member ring of 5-[2-(dimethylamino)ethyl]-8-hydroxy-2,3,4,5-
tetrahydro-1,5-benzothiazepin-4-one 8 can be tested to understand how chirality and different 
functional groups affect the biological activity. Lastly, Route 2 seems to be a viable procedure 
for the synthesis of Diltiazem or Clentiazem analogs because the starting materials and reagents 
used are relatively inexpensive and the procedure is mild. 
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